关注
Robert S. Kerbel
Robert S. Kerbel
Sunnybrook Research Institute
在 sri.utoronto.ca 的电子邮件经过验证
标题
引用次数
引用次数
年份
Angiogenesis as a therapeutic target
N Ferrara, RS Kerbel
Nature 438 (7070), 967-974, 2005
33782005
Tumor angiogenesis
RS Kerbel
New England Journal of Medicine 358 (19), 2039-2049, 2008
29292008
Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis
JML Ebos, CR Lee, W Cruz-Munoz, GA Bjarnason, JG Christensen, ...
Cancer cell 15 (3), 232-239, 2009
21362009
Clinical translation of angiogenesis inhibitors
R Kerbel, J Folkman
Nature Reviews Cancer 2 (10), 727-739, 2002
21252002
The anti-angiogenic basis of metronomic chemotherapy
RS Kerbel, BA Kamen
Nature Reviews Cancer 4 (6), 423-436, 2004
16822004
Tumor angiogenesis: past, present and the near future
RS Kerbel
Carcinogenesis 21 (3), 505-515, 2000
15812000
Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity
G Klement, S Baruchel, J Rak, S Man, K Clark, DJ Hicklin, P Bohlen, ...
The Journal of clinical investigation 105 (8), R15-R24, 2000
15052000
β1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis
JW Dennis, S Laferté, C Waghorne, ML Breitman, RS Kerbel
Science 236 (4801), 582-585, 1987
12011987
Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in …
AM Petit, J Rak, MC Hung, P Rockwell, N Goldstein, B Fendly, RS Kerbel
The American journal of pathology 151 (6), 1523, 1997
11461997
Establishment and characterization of first trimester human trophoblast cells with extended lifespan
CH Graham, TS Hawley, RC Hawley, JR MacDougall, RS Kerbel, N Khoo, ...
Experimental cell research 206 (2), 204-211, 1993
11181993
Mutant ras Oncogenes Upregulate VEGF/VPF Expression: Implications for Induction and Inhibition of Tumor Angiogenesis
J Rak, Y Mitsuhashi, L Bayko, J Filmus, S Shirasawa, T Sasazuki, ...
Cancer research 55 (20), 4575-4580, 1995
10631995
Antiangiogenic therapy in oncology: current status and future directions
GC Jayson, R Kerbel, LM Ellis, AL Harris
The Lancet 388 (10043), 518-529, 2016
8152016
Antiangiogenic therapy: impact on invasion, disease progression, and metastasis
JML Ebos, RS Kerbel
Nature reviews Clinical oncology 8 (4), 210-221, 2011
7932011
Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR
K Al-Nedawi, B Meehan, RS Kerbel, AC Allison, J Rak
Proceedings of the National Academy of Sciences 106 (10), 3794-3799, 2009
7862009
The multifaceted circulating endothelial cell in cancer: towards marker and target identification
F Bertolini, Y Shaked, P Mancuso, RS Kerbel
Nature Reviews Cancer 6 (11), 835-845, 2006
7292006
Acquired resistance to the antitumor effect of epidermal growth factor receptor-blocking antibodies in vivo: a role for altered tumor angiogenesis
A Viloria-Petit, T Crombet, S Jothy, D Hicklin, P Bohlen, JM Schlaeppi, ...
Cancer research 61 (13), 5090-5101, 2001
6912001
Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors
Y Shaked, A Ciarrocchi, M Franco, CR Lee, S Man, AM Cheung, ...
Science 313 (5794), 1785-1787, 2006
6782006
A role for survivin in chemoresistance of endothelial cells mediated by VEGF
J Tran, Z Master, JL Yu, J Rak, DJ Dumont, RS Kerbel
Proceedings of the National Academy of Sciences 99 (7), 4349-4354, 2002
6532002
Maximum tolerable dose and low-dose metronomic chemotherapy have opposite effects on the mobilization and viability of circulating endothelial progenitor cells
F Bertolini, S Paul, P Mancuso, S Monestiroli, A Gobbi, Y Shaked, ...
Cancer research 63 (15), 4342-4346, 2003
6232003
E-Cadherin–dependent Growth Suppression is Mediated by the Cyclin-dependent Kinase Inhibitor p27KIP1
B St. Croix, C Sheehan, JW Rak, VA Flørenes, JM Slingerland, RS Kerbel
The Journal of cell biology 142 (2), 557-571, 1998
6191998
系统目前无法执行此操作,请稍后再试。
文章 1–20